Helius Medical Technologies announced positive results from their PoNSTEP study, demonstrating the long-term benefits of PoNS Therapy for gait...

Coherus BioSciences announced final data from its Phase 2 trial of casdozokitug (casdozo), an IL-27-targeting antibody, combined with atezolizumab...

In this interview, we engage with David Craig from Sarcomatrix Therapeutics to discuss the development of S-969, a novel...

In this interview, we speak with Peter Weinstein, co-founder of Emervax. The discussion delves into Emervax’s innovative circular RNA...

Allurion Technologies received a patent for its enhanced, next-generation gastric balloon technology, specifically for its improved valve system. This...

Kiromic BioPharma announced positive efficacy results from its Deltacel-01 Phase 1 clinical trial of Deltacel™, an allogeneic, off-the-shelf Gamma...

NiKang Therapeutics has initiated a global Phase 1b/2 clinical trial evaluating NKT2152, an oral HIF2α inhibitor, in combination with...

Xilio Therapeutics announced initial positive Phase 2 data for vilastobart (XTX101), a tumor-activated anti-CTLA-4 antibody, combined with atezolizumab (Tecentriq®)...

The AIDS Clinical Trials Group (ACTG) launched the ACACIA study, a Phase 2 trial investigating the use of two...

RS BioTherapeutics announced positive results from a human lung tissue study of its lead compound, RSBT-001. The study showed...